Credit: Evolent Health, which provides advisory services and an IT platform to help health systems adopt an outcomes-based business model, raised $195.5 million in an upsized IPO by offering 11.5 million shares at $17, above the range of $14 to $16. The company originally planned to offer 10 million shares. Evolent Health plans to list on the NYSE under the symbol EVH. Evolent Health initially filed confidentially on 12/24/2014. J.P. Morgan and Goldman Sachs acted as lead managers on the deal.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
